The central nervous system (CNS) is an important site of involvement by acute lymphoblastic
leukemia (ALL) in adults. The prevalence is sufficiently high that prophylactic treatment is …

Background The roles of clinical etiology and symptoms, imaging findings and biochemical
parameters in predicting the prognosis of posterior reversible encephalopathy syndrome …

This study aimed to elucidate the incidence and characteristics of neurotoxicity in patients
receiving methotrexate (MTX) treatment. A retrospective analysis was performed using data …

Background Posterior reversible encephalopathy syndrome (PRES) is a distinct entity with
incompletely known predisposing factors. The aim of this study is to describe the incidence …

Discussion High‐dose intrathecal methotrexate has shown to decrease central nervous
system disease or metastasis in childhood acute lymphocytic leukemia and non‐Hodgkin …

Aim: To evaluate clinical and radiologic presentation, and neurologic outcome of pediatric
posterior reversible encephalopathy syndrome (PRES). Patients and Methods: The study …

This study investigated the management and clinical outcomes along with associated factors
of posterior reversible encephalopathy syndrome (PRES) in childhood …

Relapsed medulloblastoma (MB) has a dire prognosis, and chemotherapy remains the main
therapeutic option. We retrospectively analyzed the clinical characteristics and survival rates …

Patients with haematological malignancy are at increased risk of developing central nervous
system (CNS) infections, which are associated with significant morbidity and mortality …

Background Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by
thunderclap headaches and transient segmental cerebral arterial vasoconstriction. Many …